Little Green Pharma has launched its first dried flower cannabis medicine to help meet increasing patient demand and plug the flower shortage.
LGP Flower THC 22 – Desert Flame is a Schedule 8 medicine with 22% THC and less than 1% CBD. The product is available in a 15g container and is expected to be prescribed via inhalation using a vaporiser. It complements LGP’s existing medicinal cannabis oil product range.
Join the Cannabiz revolution
Want to stay ahead of the cannabis curve with the latest local and international news, analysis and intelligence and access to Australia's legal cannabis industry?
This article is included with our Premium subscription.
Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.
Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.